Rep. Thomas Kean Jr. Disclosed 3 Stock Trades: Stryker, J&J and ESAB

· Congress Trades

Rep. Thomas Kean Jr. disclosed 3 stock trades, Oct 30, 2026

Rep. Thomas H. Kean Jr. (NJ-7) disclosed three stock trades on October 30, 2026: sales of Stryker (SYK) and Johnson & Johnson (JNJ) dated September 30, and a purchase of ESAB dated September 29, each in the $1,001–$15,000 band.

Trade data: Bargo, compiled from U.S. House and Senate STOCK Act filings.

DateTickerCompanyType / sizePrice at trade vs. Nov 2 (Bargo est.)
Sep 29ESABESAB CorporationPurchase, $1,001–$15,000$67.60 vs. $76.30 (+12.87%)
Sep 30JNJJohnson & JohnsonSale, $1,001–$15,000$264.74 vs. $270.56 (+2.20%)
Sep 30SYKStryker CorporationSale, $1,001–$15,000$275.39 vs. $306.81 (+11.41%)

Transaction dates: Sep 29 and Sep 30, 2026. Disclosure date: Oct 30, 2026 (30 to 31 days later). Member: Rep. Thomas H. Kean Jr., NJ-7 (House).

What's been disclosed

  • Two sales: Stryker (SYK) and Johnson & Johnson (JNJ), $1,001–$15,000 each, on September 30.
  • One purchase: ESAB (ESAB), $1,001–$15,000, on September 29.
  • Price since: Bargo's estimate puts Stryker about 11.4% higher on November 2 than on the sale date, Johnson & Johnson about 2.2% higher and ESAB about 12.9% higher.

Quick FAQ

How long after the trades were they disclosed?
30 to 31 days after the trades, which were dated September 29 and 30. The STOCK Act gives members 45 days from the transaction to disclose it.

Why are the amounts ranges?
Filings report value bands such as $15,001–$50,000 instead of exact dollar amounts.

Where does the price comparison come from?
It is Bargo's estimate, comparing the price on the transaction date with the November 2 price. It is not the member's actual execution price.

Trade data from Bargo (STOCK Act filings). This post is our own summary of public filings and is not investment advice. See our Disclaimer and evidence labels.
Stock Anatomy · Last checked: November 4, 2026

Related